Important Dates (2021-2022)
Early Decision plan primary application (AMCAS) deadline
Supplemental application invitations begin for both Early Decision and Regular Decision plans
Early Decision plan supplemental application deadline
Early Decision plan admission notification
Regular Decision plan primary application (AMCAS) deadline
Regular Decision plan supplemental application deadline
Regular Decision admission rolling notifications
AMCAS Choose Your Medical School Tool “Commit to Enroll” to NEOMED deadline
Traditional Admission Pathway
Apply as a college graduate to medical school at NEOMED
The College of Medicine at NEOMED welcomes new students via traditional admission that have not started in an Early Assurance pathway with a partner university. Candidates applying to the traditional admission pathway to NEOMED as a first-year medicine student should begin the application process through the American Medical College Application Service (AMCAS). As a member of the American Association of Medical Colleges (AAMC), NEOMED participates in a common application service and abides by all AAMC deadlines and practices.
Who should apply?
Successful candidates for the College of Medicine at NEOMED include individuals:
- Who possess the intelligence, integrity, and personal, and emotional characteristics necessary for them to become competent physicians.
- Who seek careers as physicians practicing patient centered care.
- Who seek to serve as leaders of transformative change in healthcare in Ohio and beyond.
- Who strive to uphold the mission, vision and values of the College
EARLY DECISION ADMISSION
All Traditional Admission applicants to the M.D. program who consider NEOMED their medical school of choice and are strongly aligned with its mission are encouraged to apply electing the Early Decision Plan.
- Early Decision is binding, which means that candidates who receive offers of admission are obligated by AMCAS policy to attend NEOMED should they wish to attend any allopathic school of medicine.
- All Early Decision applicants must present valid MCAT and Altus assessment CASPer scores, apply through AMCAS by August 1, and have the secondary application (by invitation only) complete and verified to the Office of Admissions by September 1 of the year prior to anticipated enrollment.
- Notification to the applicant regarding admission is given by October 1. If selected, an EDP admit receives the benefit of early notification of acceptance and is, therefore, obligated to attend the NEOMED College of Medicine under American Association of Medical Colleges (AAMC) admission policy. If not selected for admission through the early decision plan, applicants may then apply to other medical schools. For more information regarding consideration of whether the early decision program is right for you, visit students-residents.aamc.org.
EARLY DECISION PLAN: OHIO ADMISSION ADVANTAGE
While all traditional admission candidates are encouraged to consider the Early Decision Plan, NEOMED utilizes the early decision plan to extend highly favorable consideration toward a number of Ohio candidates with above average academic credentials.
- For these purposes, an Ohio candidate is any early decision plan applicant who either maintains permanent residence in Ohio and indicates as much on his or her AMCAS application or who attends/attended an Ohio institution of post-secondary education (university, college, community college) whether state or private
- Ohio candidates with above average academic profiles selecting the early decision plan receive a significant advantage over candidates that elect the regular decision plan. Ohio candidates pursuing admission to NEOMED outside of early assurance are strongly encouraged to apply using the early decision plan to maximize their chances for admission to medical school in the event that NEOMED is their first choice.
- All early decision policies, procedures, and deadlines apply to the Ohio Admission Advantage. For full details and policies, please refer to the NEOMED Compass (catalogue and handbook).
Application Eligibility Guidelines
All traditional admission candidates must:
- Possess at least a baccalaureate (four-year) degree from a U.S. regionally accredited college or university or a Canadian University prior to enrolling at NEOMED (applicants may be in their final year of progress toward a degree prior to graduation at the time of application).
- Be a U.S citizen/U.S. permanent resident (latter must submit documentation of status during application process). This requirement still applies to Canadian University students.
Applicants must complete:
• Two semesters of Organic Chemistry and Labs
• Two semesters of Physics and Labs
• Two semesters of Biology and Labs
• One semester of Biochemistry
Applicants are strongly recommended to have completed coursework in:
- Cell Biology
- English Composition
- Molecular Biology
Competitive Academic Profile
An academic profile for competitive traditional admission candidates includes:
- Overall GPA: 3.52 – 3.84 (middle 50% of acceptances)
- Overall GPA average: 3.67
- College BCPM (Biology, Chemistry, Physics and Math) GPA: 3.40 – 3.85 (middle 50% of acceptances)
- Overall BCPM GPA average: 3.60
- MCAT score: 505 – 511 (middle 50% of acceptances)
- MCAT average: 508
How to Apply
Students apply to NEOMED using the American Medical College Application Service (AMCAS) application as early as June 1 of the year preceding anticipated enrollment in medical school.
Fill out your AMCAS application, and select NEOMED as a school to receive the application. You may wish to make plans to take the Altus Assessments CASPer test, although CASPer test results are not required for NEOMED at the time of AMCAS application for initial screening and review.
Once your application has been verified by AMCAS, NEOMED may send you an invitation to complete your secondary application beginning July 31, 2020 and on a rolling basis thereafter until one week prior to the NEOMED supplemental application deadline. There is a $ 95.00 fee for the secondary application.
NEOMED also requires the CASPer situational judgement test. Please visit takecasper.com for more information, test dates, and to register for the U.S. Medicine CSP 10111 test as a part of the Altus Assessments Suite. All candidates for admission are required to take the CASPer. Candidates must submit CASPer scores to NEOMED in order to receive interview consideration.
Note – NEOMED Secondary application is by invitation only following screening and review of AMCAS applications. Applicants should refer to AMCAS to begin application to medical school.
Watch for email notification that your file is complete and await word on a possible interview between September and March.
Required Application Materials
- AMCAS Application
- Supplemental application
- Personal Statements
- CASPer test results (part of the Altus Assessment Suite)
- MCAT scores
- $ 95.00 Secondary Application Fee
Letters of evaluation are neither required nor accepted for this program.
NEOMED will not accept MCAT scores older than three years at the time of the month of matriculation.
As an applicant seeking admission to NEOMED, you are required to pay a non-refundable supplemental application fee of $95. An online payment will be made when you submit your supplemental application.
You may qualify for a supplemental application fee waiver if you qualified for a fee waiver through AMCAS. Follow the instructions on the NEOMED supplemental application to receive the fee waiver.
COLLEGE OF GRADUATE STUDIES M.D. PATHWAYS
NEOMED MASTER’S PATHWAY
NEOMED students currently enrolled in any NEOMED master’s degree program that successfully apply through AMCAS for the M.D. program will receive an invitation to interview for a seat in medical school at NEOMED. “Successful application” constitutes the following:
• Apply to NEOMED through AMCAS by either the early or regular decision plan deadlines. Candidates who have already completed a year of study in a NEOMED master’s degree program are encouraged to apply using the early decision plan.
• Present credentials, including grades and MCAT score, that meet NEOMED screening criteria to receive an invitation for a secondary application.
• Complete and submit a secondary application to NEOMED through AMCAS by either the early or regular decision plan deadlines.
• Candidates indicate that they are enrolled at NEOMED on their AMCAS applications at the time of application to be eligible.
• Complete master’s degree program at NEOMED if admitted to NEOMED COM.
NEOMED UNDERREPRESENTED STUDENTS IN MEDICINE (URIM) PATHWAY
Selected NEOMED Underrepresented Students in Medicine (URIM) candidates may qualify for a pathway through the NEOMED College of Graduate Studies offering early assurance to medical school. NEOMED URIM Pathway candidates will receive early assurance to the M.D. program at NEOMED with admission to the College of Medicine based upon their performance in graduate school at NEOMED. NEOMED URIM Pathway candidates will not need to re-take the MCAT. NEOMED URIM Pathway eligibility is as follows:
• Generally, students who are categorized as underrepresented in medicine (URIM) should be underrepresented minorities in medicine and/or students from educationally and/or socioeconomically disadvantaged backgrounds seeking to enter medical school.
• Application to the NEOMED URIM Pathway is by invitation only. In order to be eligible, NEOMED URIM candidates must have applied to the NEOMED College of Medicine M.D. program through AMCAS for the current admission cycle. URIM candidates that successfully apply, complete medical school interviews at NEOMED, and advance to the alternate list (wait list) stage may be invited to apply for the NEOMED
URIM early assurance pathway.
• Consideration of participation in the NEOMED URIM Pathway on the part of candidates will have no impact on their ability to receive a seat in the M.D. program for the current admission cycle should an M1 seat become available.
• Selected alternate list candidates will be invited to apply for the NEOMED URIM Pathway in April when the M.D. program alternate list is established. Eligible candidates must then apply for admission into a designated master’s degree program at NEOMED by published deadlines. In most cases, the admission application process will use previously submitted AMCAS application credentials along with a signed release and supplemental application statement from the candidate without an additional lengthy and redundant application process. At present the only participating NEOMED master’s program is the Master of Modern Anatomical Sciences. Other programs may be added at a later date.
• NEOMED URIM candidates must then meet admission criteria into the specific master’s program of study to receive admission. An interview with the master’s program admission committee may be required.
• Upon admission to a NEOMED master’s program, NEOMED URIM Pathway candidates must matriculate into graduate study and enroll for that academic year.
• NEOMED URIM pathway students should not retake the MCAT. Instead, their early assurance admission decision will be based upon their academic achievement in their NEOMED master’s program coursework. Candidates achieving NEOMED grade point averages of 3.0 or better, fewer than two “C”s and no grade of less than a “C” as of March 1st will be admitted to the M.D. program in the College of Medicine as M1 students for the subsequent academic year to begin in July/August. Admission is contingent upon
successful completion of the master’s degree.
• It should be noted that admission into the M.D. program via the NEOMED URIM early assurance pathway is not automatic and actual admission is earned through performance in NEOMED coursework. The seat in medical school is assured if successful grades are achieved and the student is on pace to graduate from the master’s degree program at NEOMED.
For full details and policies, please refer to the most recently published NEOMED COMPASS (catalog and handbook) in the applying for admission section.